Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Zala

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|September 28, 1991
Notification of hepatitis AR White, J Cheesbrough, D Zala
Cellular and Molecular Life Sciences : CMLS|October 17, 2006
Huntington's disease: from huntingtin function and dysfunction to therapeutic strategiesM Borrell-Pagès, D Zala, S Humbert, et al.
Neurobiology of Disease|July 10, 2001
Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's diseaseL P de Almeida, D Zala, P Aebischer, et al.
Eye (London, England)|January 1, 1990
Meningococcal conjunctivitisS B Kaye, E M Molyneux, D Zala, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|September 28, 1991
Notification of hepatitis AR White, J Cheesbrough, D Zala
Cellular and Molecular Life Sciences : CMLS|October 17, 2006
Huntington's disease: from huntingtin function and dysfunction to therapeutic strategiesM Borrell-Pagès, D Zala, S Humbert, et al.
Neurobiology of Disease|July 10, 2001
Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's diseaseL P de Almeida, D Zala, P Aebischer, et al.
Eye (London, England)|January 1, 1990
Meningococcal conjunctivitisS B Kaye, E M Molyneux, D Zala, et al.
Pageof 1